FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/09/036445 [Registered on: 13/09/2021] Trial Registered Prospectively
Last Modified On: 09/09/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Single Arm Study 
Public Title of Study   Volume of 0.5% ropivacaine needed to produce anaesthesia of upper limb in 50% of patients using ultrasound guided multiple injection lateral sagittal infraclavicular plexsus block 
Scientific Title of Study   Median effective volume of 0.5% ropivacaine for ultrasound guided multiple injection lateral sagittal infraclavicular plexus block: a dose finding study  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Jeetinder Kaur Makkar 
Designation  Professor 
Affiliation  Post Graduate Institute of Medical Education and Research 
Address  Department of Anaesthesia PGIMER, Chandigarh
Sector 12 , Chandigarh
Chandigarh
CHANDIGARH
160012
India 
Phone  7087009510  
Fax    
Email  jeet1516@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Jeetinder Kaur Makkar 
Designation  Professor 
Affiliation  Post Graduate Institute of Medical Education and Research 
Address  Department of Anaesthesia PGIMER, Chandigarh
Sector 12 , Chandigarh

CHANDIGARH
160012
India 
Phone  7087009510  
Fax    
Email  jeet1516@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Jeetinder Kaur Makkar 
Designation  Professor 
Affiliation  Post Graduate Institute of Medical Education and Research 
Address  Department of Anaesthesia PGIMER, Chandigarh
Sector 12 , Chandigarh

CHANDIGARH
160012
India 
Phone  7087009510  
Fax    
Email  jeet1516@gmail.com  
 
Source of Monetary or Material Support  
Post Graduate institute of Medical Education & Research, Chandigarh 
 
Primary Sponsor  
Name  Post Graduate Institute of Medical Education Research 
Address  Sector 12, Chandigarh, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Jeetinder kaur Makkar  Post Graduate institute for Medical Education and Research  Department of Anaesthesia, Trauma OT Complex, 3rd floor, Advanced trauma centre, PGIMER, Sector 12 Sector 12 ,
Chandigarh
CHANDIGARH 
7087009510

jeet1516@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical, (2) ICD-10 Condition: M968||Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Infraclavicular brachial plexus block  The patients will be placed supine with the arm to be blocked abducted. We will use a high-frequency (5–12 MHz) ultrasound probe (Sonosite, Inc. Bothell. WA 9802 USA). Transducer will be positioned in the parasagittal plane in the lateral infraclavicular space to identify the axillary artery. Once the artery is identified, we will identify the hyperechoic cords of the brachial plexus and their corresponding positions relative to the artery. 18G 10mm stimuplex needle will be inserted in-plane from the cephalad end of the probe, with the insertion point just inferior to the clavicle. The needle position will be refined until stimulation is achieved at a current of ∼0.5 mA. Needle insertion and injection will be considered intraneural if nerve stimulation at a current of 0.2 mA (0.1 ms) or less results in an evoked motor response or if a high resistance (pressure) to injection or nerve swelling was noticed upon initiating the injection. In these instances, the injection will be immediately stopped, and patients with suspected intraneural injections will be excluded from analyses. Operator’s objective will be to selectively surround each sonographically imaged brachial plexus cord with predetermined volume of local anaesthetic; however, if a cord could not be imaged, local anaesthetic placement will be done on an arbitrary basis according to an imaginary clock face in the following sequential order: posterior cord at 6 o’clock, lateral cord at 8 o’clock, and medial cord at 2 o’clock (in the triangular anterior space between axillary artery and vein). The needle bevel will be faced dorsally for each of the 3 positions; however, when manipulation will be performed close to the artery, the bevel will be directed away from the artery. Following this, a 20-gauge catheter will be inserted through the needle and advanced 1- 2 cms beyond the needle tip, to be localised dorsolateral to the posterior cord of brachial plexus. The needle will be then withdrawn over the catheter. All catheters will be tunnelled under the skin and the site will be covered with clear occlusive dressing 
Comparator Agent  Not applicable  Not applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients with American Society of Anesthesiologists (ASA) physical status I-II patients, in the age group of 18-60 years, with a body mass index (BMI) between 18 and 30 kg.m-2, scheduled to undergo forearm and hand surgeries will be assessed for eligibility 
 
ExclusionCriteria 
Details  Patients with local infection at the block site, coagulopathy, sepsis, BMI>30, allergy to local anesthetics, uncontrolled hypertension or ischemic heart disease, renal or hepatic dysfunction, pre-existing neurological deficits, prior surgery in the infraclavicular fossa, psychiatric illness, patients who failed to understand the scoring systems used in the study and patients who refused to give consent for the study will be excluded. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
The primary objective will be to estimate MEV90 for multiple-injection US-guided ICB. Volume assignment will be carried out using a biased coin design (BCD) up-and-down sequential method (UDM), where the volume administered to each patient will depend upon the response of previous patient. First subject will receive 21 ml based upon a previous study MEV50 of 19 ml in patients receiving ultrasound-guided LSIB with ropivacaine 7.5 mg/ml. based on the response of the previous patient. In case of failure, the next subject will receive a higher volume (0.5ml/ cord). If the previous patient had a successful block, the next subject will be randomized to a lower volume  30 minutes after performance of block 
 
Secondary Outcome  
Outcome  TimePoints 
Time to requirement of first bolus, mean pain scores at various time intervals  Baseline ie on shifting to PACU, 2hrs, 4hrs , 8hrs, 12hrs, 24hrs 
 
Target Sample Size   Total Sample Size="45"
Sample Size from India="45" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   20/09/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Relatively large volumes of local anaesthetic (LA) and/or multiple injections are used to produce successful BPB. The minimum effective volume of LA needed for producing a multiple injection LICF brachial plexus block is not known. Knowledge of minimum effective volume is very important, so as to reduce the risk of systemic toxicity without affecting the efficacy of block. In a dose finding study done for single injection technique, the MEV in 95% of patients for an ultrasound-guided LSIB with ropivacaine 7.5 mg/ml was estimated to be 31 ml (95% CI, 18–45 ml). Technique involved injection of drug in periarterial sector from 3 to 11 o’clock and within 2cm of axis of axillary artery. We will inject selectively surround each sonographically imaged brachial plexus cord and define the local anesthetic required for multiple injection technique

 

 

 

 

 
Close